Amoxilan 250 mg/5 ml - Trockensaft
Recall
|
Medicines
|
12/04/2024
The marketing authorisation holder informed its customers on April 12, 2024, that a glass splinter was found in a bottle of the mentioned batch. Although it is assumed to be an isolated case, it cannot be ruled out that other packs from the same batch are affected by this defect. For this reason, the batch in question is being recalled as a precautionary measure. This recall only affects the 60ml bottles.
| Name of the medicinal product | Amoxilan 250 mg/5 ml - Trockensaft |
|---|---|
| Marketing authorisation number(s) | 1-20613 |
| CIP code | 1286346 |
| Marketing authorisation holder | G.L. Pharma GmbH |
| Manufacturer | PenCef Pharma GmbH |
| Batch number(s) | 23K11 |
| Expiry date | 10/31/2026 |
| Classification of the recall | 1 |
| Depth of recall | Patients |
| BASG reference number | INS-640.001-4717 |
| Safety warnings Link | Safety information on the quality defect/recall of "Amoxilan 250 mg/5 ml - Trockensaft" |
Further inquiry note
Page last modified:
12/04/2024